Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insurance Group Regulatory News (SBRE)

Share Price Information for Sabre Insurance Group (SBRE)

Share Price is delayed by 15 minutes
Get Live Data
163.60    2.00 (1.24%)
Bid:
164.20
Ask:
164.60
Spread: 0.40 (0.244%)
Market Cap: £398.70m
SBRE Live PriceLast checked at - London Stock Exchange

Intraday Sabre Insurance Group Share Chart

Trading Update

22 Oct 2024 07:00

RNS Number : 0295J
Sabre Insurance Group PLC
22 October 2024
 

22 October 2024

Sabre Insurance Group plc

Trading Update

On track for record premium income and strong, on-target profit

Sabre Insurance Group plc (the "Group" or "Sabre"), one of the UK's leading motor insurance underwriters, today provides an update on trading for the period from 1 July 2024 to 30 September 2024.

 

Unaudited

Nine months ended

30 September

 

Year ended

31 December

 

2024

2023

% Change

 2023

Gross written premium - Motor Vehicle

£165.6m

£140.5m

18%

£199.0m

Gross written premium - Motorcycle

£8.2m

£10.7m

(23%)

£11.8m

Gross written premium - Taxi

£12.7m

£11.0m

15%

£14.3m

Gross written premium - Total

£186.5m

£162.2m

15%

£225.1m

Post-dividend solvency capital ratio

195%

191%

 

171%

 

Key Highlights

- Gross Written Premium up 15% against the same period in 2023, on-track to deliver record Gross Written Premium for the year

- Continued to increase rates to cover elevated claims inflation, in contrast to the wider market

- Policies continue to be written at target margins - underpinning profitable growth for this year and positioning Sabre well into 2025

- Focus on disciplined underwriting reflected in expectation of a profitable out-turn across all product lines

- Continued strong capital generation supports confidence in the ability to pay an attractive dividend for the year

- Policy count as at 30 September 2024: Motor - 230k (30 September 2023: 222k), Motorcycle - 38k (30 September 2023: 45k), Taxi - 11k (30 September 2023: 13k)

 

Capital Markets Event

- A capital markets session for investors and analysts, focussed on how our strategy and business model will deliver growth and value for our shareholders in the medium-term, will be held on 5th December 2024

 

Market trends

- Some signs of claims inflation moderating, but remains at a high single-digit level

- Despite this, increasing competition for volume in the mass-market is evident in clear signs of market price reductions

- However, level of market discounting far lower than the extreme price movements seen in recent years suggesting a more stable trading environment

- We continue to expect market prices will need to increase to reflect current levels of inflation

- We note the recent announcement of a cross-government motor insurance taskforce, supported by industry experts, formed to help identify the factors behind rapidly rising premiums. We are pleased that this is primarily focussing on options to tackle the underlying cost inflation driving premium increases

- We also note the Financial Conduct Authority's recently announced premium finance market study. We look forward to engaging with the regulator as appropriate, and can confirm our full compliance with fair value rules and our belief that we have very limited regulatory exposure. The proportion of our profits expected to be generated through premium finance income remains minimal

 

Full-year profit guidance reaffirmed, slight softening in gross written premium

- We continue to anticipate strong year-on-year premium growth, and profit in line with current market expectations

- We expect our year-on-year premium growth to be moderated slightly and to be in-line with our view of high single digit claims inflation

 

Geoff Carter, Chief Executive Officer of Sabre, commented:

"I'm pleased with our performance at the Q3 stage and look forward with confidence to a strong full-year result. Importantly, our resolute price discipline means we expect to continue this good performance in future periods.

We have seen clear signs that market pricing has softened considerably during the summer. Our view is that market price movements outstrip any potential short-term benefits from a slight softening in claims inflation. We remain confident in our view on inflation and that market pricing will have to reflect this in due course.

Our proven, disciplined strategy has enabled us to adapt to changing market conditions successfully and rapidly. We were able to grow very strongly in attractive market conditions in H1, and then to accept slightly lower, but still good, volumes in Q3.

I am also excited that we are now completing the foundation work that will support our multi-year growth strategy. I look forward to discussing this at an update session for analysts and investors in December and updating on our progress in future results presentations."

 

Investor enquiries

01306 747 272

Sabre Insurance Group plc

Geoff Carter / Adam Westwood

Media enquiries

020 7353 4200

Teneo

sabre@teneo.com

James Macey White / Ffion Dash

 

LEI Code: 2138006RXRQ8P8VKGV98

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFEUFAFELSEES
Date   Source Headline
9th Aug 201912:02 pmRNSPrice Monitoring Extension
31st Jul 20198:34 amRNSHolding(s) in Company
30th Jul 20197:00 amRNSHalf-year Report
11th Jul 20195:08 pmRNSDirector/PDMR Shareholding
29th May 20199:09 amRNSHolding(s) in Company
23rd May 201911:33 amRNSAGM Statement
23rd May 20197:00 amRNSTrading Statement
10th May 20194:49 pmRNSHolding(s) in Company
30th Apr 20194:16 pmRNSDirector/PDMR Shareholding
29th Apr 20194:26 pmRNSDirector/PDMR Shareholding
23rd Apr 20195:04 pmRNSDirector/PDMR Shareholding
18th Apr 201911:18 amRNSNotice of AGM
12th Apr 20198:43 amRNSDirector/PDMR Shareholding
10th Apr 20192:58 pmRNSDirector/PDMR Shareholding
8th Apr 201910:40 amRNSDirector/PDMR Shareholding
28th Mar 20197:00 amRNSFinal Results
5th Mar 20193:32 pmRNSHolding(s) in Company
26th Feb 20197:00 amRNSHolding(s) in Company
21st Jan 201910:06 amRNSHolding(s) in Company
28th Dec 20184:15 pmRNSHolding(s) in Company
24th Dec 20181:22 pmRNSRandgold Resources
5th Dec 201811:42 amRNSHolding(s) in Company
16th Oct 20189:12 amRNSDirector/PDMR Shareholding
11th Oct 20187:00 amRNSTrading Update
18th Sep 20188:51 amRNSHolding(s) in Company
7th Sep 20187:00 amRNSHolding(s) in Company
7th Sep 20187:00 amRNSHolding(s) in Company
7th Sep 20187:00 amRNSHolding(s) in Company
6th Sep 201811:58 amRNSHolding(s) in Company
6th Sep 201811:55 amRNSHolding(s) in Company
5th Sep 20187:00 amRNSResults of Placing of Sabre Insurance Group Shares
4th Sep 20184:50 pmRNSProposed Placing of Sabre Insurance Group Shares
13th Aug 20188:49 amRNSHolding(s) in Company
31st Jul 20187:05 amRNSDirector Declaration
31st Jul 20187:00 amRNSHalf-year Report
6th Jul 20189:07 amRNSHolding(s) in Company
6th Jul 20189:00 amRNSNotice of Results
27th Jun 201810:59 amRNSCancellation of share premium account
21st Jun 20182:00 pmRNSDirector/PDMR Shareholding
18th Jun 20182:58 pmRNSDirectorate Change
31st May 20183:34 pmRNSHolding(s) in Company
31st May 20187:00 amRNSHolding(s) in Company
31st May 20187:00 amRNSHolding(s) in Company
30th May 20187:00 amRNSResults of Placing of Sabre Insurance Group Shares
29th May 20185:01 pmRNSProposed Placing of Sabre Insurance Group Shares
24th May 20182:48 pmRNSDirector/PDMR Shareholding
24th May 201811:24 amRNSAGM Statement
24th May 20187:00 amRNSTrading Update
18th May 201811:37 amRNSCompany Secretary Appointment
4th May 20184:09 pmRNS2017 Solvency and Financial Condition Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.